Carelabs Co.,Ltd (KOSDAQ:263700)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,973.00
+38.00 (1.96%)
At close: Sep 11, 2026

Carelabs Co.,Ltd Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
74,00681,69483,18781,82787,60793,934
74,00681,69483,18781,82787,60793,934
Revenue Growth
-14.97%-1.80%1.66%-6.60%-6.73%22.52%
Cost of Revenue
2,1071,6781,1872,2533,1574,857
Gross Profit
71,89980,01682,00079,57484,45189,077
Selling, General & Admin
73,44277,64479,56781,76183,20578,782
Research & Development
1,8472,0482,5593,8112,7673,502
Amortization of Goodwill & Intangibles
479.42490.96520.19698.61,2941,369
Other Operating Expenses
455.91410.42474.29583.38492.57453.78
Operating Expenses
78,24082,90886,48591,27391,13186,771
Operating Income
-6,341-2,892-4,485-11,698-6,6812,306
Interest Expense
-1,102-1,390-3,118-2,996-2,504-1,502
Interest & Investment Income
846.941,030865.38694.04761.71456.59
Earnings From Equity Investments
246.36310.38-566.9175.164.53625.93
Currency Exchange Gain (Loss)
-16.5-4.75-5.7-10.14101.52-5.24
Other Non Operating Income (Expenses)
-430.45-244.067,260-1,930-5,255-176.1
EBT Excluding Unusual Items
-6,797-3,190-50.19-15,765-13,5731,705
Gain (Loss) on Sale of Investments
956.28984.09-8,320-1,678-480.374,418
Gain (Loss) on Sale of Assets
-2.625,635-4,496-306.12-1,73516.53
Asset Writedown
---6,277-4,434-10,979-2,204
Other Unusual Items
--4.66535.39-22.13-
Pretax Income
-5,84323,429-19,139-21,648-26,7893,936
Income Tax Expense
821.513,918531.112,219-400.362,694
Earnings From Continuing Operations
-6,66519,512-19,670-23,867-26,3881,242
Minority Interest in Earnings
-638.56-332.42-610.34-603.28264.4811.02
Net Income
-7,30319,179-20,280-24,470-26,1241,253
Net Income to Common
-7,30319,179-20,280-24,470-26,1241,253
Net Income Growth
------71.06%
Shares Outstanding (Basic)
191919191817
Shares Outstanding (Diluted)
191919191817
Shares Change
-0.00%-0.03%2.25%5.73%4.14%-0.11%
EPS (Basic)
-376.05988.62-1045.00-1289.28-1455.2072.70
EPS (Diluted)
-376.05988.62-1045.00-1289.28-1455.2072.70
EPS Growth
------74.44%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-23,114-15,179-4,202-12,536-9,816-40,071
Free Cash Flow Per Share
-1190.14-782.40-216.51-660.50-546.80-2324.59
Gross Margin
97.15%97.95%98.57%97.25%96.40%94.83%
Operating Margin
-8.57%-3.54%-5.39%-14.30%-7.63%2.46%
Profit Margin
-9.87%23.48%-24.38%-29.90%-29.82%1.33%
Free Cash Flow Margin
-31.23%-18.58%-5.05%-15.32%-11.21%-42.66%
EBITDA
-3,63027.76-829.86-7,273-2,6505,128
EBITDA Margin
-4.91%0.03%-1.00%-8.89%-3.02%5.46%
D&A For EBITDA
2,7112,9193,6554,4264,0302,821
EBIT
-6,341-2,892-4,485-11,698-6,6812,306
EBIT Margin
-8.57%-3.54%-5.39%-14.30%-7.63%2.46%
Effective Tax Rate
-16.72%---68.45%
Advertising Expenses
-14,57113,70811,89811,3085,399